Jabbour E, Apperley J, Cortes J, Rea D, et al. Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials. Leukemia 2024 Jan 29. doi: 10.1038/s41375-024-02159.
PMID: 38287132